These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17689369)

  • 1. 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users.
    Ellard J
    Int J Drug Policy; 2007 May; 18(3):225-34. PubMed ID: 17689369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice.
    Treloar C; Laybutt B; Jauncey M; van Beek I; Lodge M; Malpas G; Carruthers S
    Int J Drug Policy; 2008 Feb; 19(1):59-65. PubMed ID: 18312820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
    Hopwood M; Treloar C
    Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing hepatitis C: 'common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs.
    Davis M; Rhodes T; Martin A
    Soc Sci Med; 2004 Nov; 59(9):1807-18. PubMed ID: 15312916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
    Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When the dragon's awake: a needs assessment of people injecting drugs in a small urban centre.
    Gustafson DL; Goodyear L; Keough F
    Int J Drug Policy; 2008 Jun; 19(3):189-94. PubMed ID: 18472260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'It's your life!': injecting drug users, individual responsibility and hepatitis C prevention.
    Fraser S
    Health (London); 2004 Apr; 8(2):199-221. PubMed ID: 15068637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injecting nation: achieving control of hepatitis C in Australia.
    Wodak A
    Drug Alcohol Rev; 1997 Sep; 16(3):275-84. PubMed ID: 16203436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada.
    Wozniak L; Prakash M; Taylor M; Wild TC
    Int J Drug Policy; 2007 Oct; 18(5):388-96. PubMed ID: 17854727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia.
    Rhodes T; Zikic B; Prodanović A; Kuneski E; Bernays S
    Soc Sci Med; 2008 Mar; 66(6):1437-47. PubMed ID: 18201809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
    Harris M; Rhodes T
    Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
    Larance B; Degenhardt L; Copeland J; Dillon P
    Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Jailbreak Health Project--incorporating a unique radio programme for prisoners.
    Minc A; Butler T; Gahan G
    Int J Drug Policy; 2007 Oct; 18(5):444-6. PubMed ID: 17854735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users.
    Tucker T; Fry CL; Lintzeris N; Baldwin S; Ritter A; Donath S; Whelan G
    Addiction; 2004 Sep; 99(9):1157-66. PubMed ID: 15317636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The organization of a community: community-based prevention of injecting drug use-related health problems.
    Carruthers S
    Subst Use Misuse; 2007; 42(12-13):1971-7. PubMed ID: 18075921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
    Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
    Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injecting drug users: a stigmatised and stigmatising population.
    Simmonds L; Coomber R
    Int J Drug Policy; 2009 Mar; 20(2):121-30. PubMed ID: 17981451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.